{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 35755
    }
  },
  "results": [
    {
      "safetyreportversion": "4",
      "safetyreportid": "10005951",
      "primarysourcecountry": "JP",
      "occurcountry": "JP",
      "transmissiondateformat": "102",
      "transmissiondate": "20150326",
      "reporttype": "1",
      "serious": "1",
      "seriousnessdeath": "1",
      "seriousnessother": "1",
      "receivedateformat": "102",
      "receivedate": "20140313",
      "receiptdateformat": "102",
      "receiptdate": "20140903",
      "fulfillexpeditecriteria": "1",
      "companynumb": "PHHY2014JP030245",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "NOVARTIS",
        "duplicatenumb": "PHHY2014JP030245"
      },
      "primarysource": {
        "reportercountry": "JP",
        "qualification": "3",
        "literaturereference": "ISHIKAWA T.. A CASE OF BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW IN A PATIENT WHO HAD RECEIVED INTRAVENOUS BISPHOSPHONATES. JAPANESE JOURNAL OF CANCER AND CHEMOTHERAPY. 2014;41 (2):225-227"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientonsetage": "74",
        "patientonsetageunit": "801",
        "patientweight": "44",
        "patientsex": "2",
        "reaction": [
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Gingival swelling",
            "reactionoutcome": "3"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Renal failure chronic",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Gingivitis",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Periodontitis",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Oral disorder",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Exposed bone in jaw",
            "reactionoutcome": "3"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Tenderness",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Renal impairment",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Gingival bleeding",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Breast cancer stage II",
            "reactionoutcome": "5"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Aortic valve incompetence",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Anaemia",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Mitral valve disease mixed",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Nephrogenic anaemia",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Gingival erythema",
            "reactionoutcome": "3"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Loose tooth",
            "reactionoutcome": "3"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Malignant neoplasm progression",
            "reactionoutcome": "5"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Angina pectoris",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Osteonecrosis of jaw",
            "reactionoutcome": "3"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Pain in jaw",
            "reactionoutcome": "3"
          },
          {
            "reactionmeddraversionpt": "17.1",
            "reactionmeddrapt": "Bacterial infection",
            "reactionoutcome": "6"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "2",
            "medicinalproduct": "XELODA",
            "drugstructuredosagenumb": "2100",
            "drugstructuredosageunit": "003",
            "drugdosagetext": "2100 MG, DAILY",
            "drugadministrationroute": "048",
            "drugindication": "BREAST CANCER STAGE II",
            "drugstartdateformat": "102",
            "drugstartdate": "20041216",
            "drugenddateformat": "102",
            "drugenddate": "20070323",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "activesubstance": {
              "activesubstancename": "CAPECITABINE"
            },
            "openfda": {
              "application_number": [
                "NDA020896"
              ],
              "brand_name": [
                "XELODA"
              ],
              "generic_name": [
                "CAPECITABINE"
              ],
              "manufacturer_name": [
                "H2-Pharma, LLC"
              ],
              "product_ndc": [
                "61269-475",
                "61269-470"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "CAPECITABINE"
              ],
              "rxcui": [
                "200327",
                "200328",
                "213292",
                "213293"
              ],
              "spl_id": [
                "32dd0155-c5cb-49c2-9b74-74f40df22df7"
              ],
              "spl_set_id": [
                "e702d84d-7162-4751-bf37-d724cc7e45a5"
              ],
              "package_ndc": [
                "61269-470-60",
                "61269-475-12"
              ],
              "nui": [
                "N0000000233",
                "N0000175595"
              ],
              "pharm_class_moa": [
                "Nucleic Acid Synthesis Inhibitors [MoA]"
              ],
              "pharm_class_epc": [
                "Nucleoside Metabolic Inhibitor [EPC]"
              ],
              "unii": [
                "6804DJ8Z9U"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "FARESTON",
            "drugindication": "BREAST CANCER STAGE II",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "activesubstance": {
              "activesubstancename": "TOREMIFENE CITRATE"
            },
            "openfda": {
              "application_number": [
                "NDA020497"
              ],
              "brand_name": [
                "FARESTON"
              ],
              "generic_name": [
                "TOREMIFENE CITRATE"
              ],
              "manufacturer_name": [
                "Kyowa Kirin, Inc."
              ],
              "product_ndc": [
                "42747-327"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "TOREMIFENE CITRATE"
              ],
              "rxcui": [
                "152880",
                "313428"
              ],
              "spl_id": [
                "11857fbe-6c5e-485e-b5d4-7f091a331928"
              ],
              "spl_set_id": [
                "2cab8dd1-3a10-48e6-86ce-0e5275ed49e5"
              ],
              "package_ndc": [
                "42747-327-30",
                "42747-327-72"
              ],
              "unii": [
                "2498Y783QT"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "CHEMOTHERAPEUTICS",
            "actiondrug": "5",
            "drugrecurreadministration": "3",
            "activesubstance": {
              "activesubstancename": "UNSPECIFIED INGREDIENT"
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "TAMOXIFEN CITRATE.",
            "drugadministrationroute": "048",
            "drugindication": "BREAST CANCER STAGE II",
            "drugstartdateformat": "102",
            "drugstartdate": "19970902",
            "drugenddateformat": "102",
            "drugenddate": "19990928",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "activesubstance": {
              "activesubstancename": "TAMOXIFEN CITRATE"
            },
            "openfda": {
              "application_number": [
                "ANDA213358",
                "NDA021807",
                "ANDA075797",
                "ANDA070929",
                "ANDA074732"
              ],
              "brand_name": [
                "TAMOXIFEN CITRATE",
                "SOLTAMOX"
              ],
              "generic_name": [
                "TAMOXIFEN CITRATE"
              ],
              "manufacturer_name": [
                "Aurobindo Pharma Limited",
                "Mayne Pharma",
                "Mayne Pharma Commercial LLC",
                "Dr. Reddy's Labratories Inc.",
                "Actavis Pharma, Inc.",
                "Mylan Pharmaceuticals Inc."
              ],
              "product_ndc": [
                "59651-299",
                "59651-300",
                "51862-682",
                "51862-643",
                "51862-642",
                "75907-058",
                "75907-059",
                "0591-2472",
                "0591-2473",
                "0378-0144",
                "0378-0274"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "TAMOXIFEN CITRATE"
              ],
              "rxcui": [
                "198240",
                "313195",
                "389230",
                "644304"
              ],
              "spl_id": [
                "a596c715-8e30-43c1-aba3-4fe5de6729fa",
                "5bcbc281-342c-4b05-8409-53a08b1fc9f6",
                "433f16e8-7df7-8a6e-e063-6394a90a7c4c",
                "f632608a-0743-4a7e-33a8-2ae28eccfcb9",
                "20254a14-2e07-4279-8263-c63b6a71d861",
                "2c1fe025-1eb2-4b2f-b8c9-5d0cfc3c683e"
              ],
              "spl_set_id": [
                "a596c715-8e30-43c1-aba3-4fe5de6729fa",
                "1e6ff055-590c-41e6-9530-1fdf04cdbd02",
                "c82205a3-ae0c-4ce5-b04b-9581cd8c70d4",
                "c6c6a643-57d6-7ea5-7da0-e8a66802468a",
                "9b8a4211-120f-4981-ad69-928accb97637",
                "7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0"
              ],
              "package_ndc": [
                "59651-299-60",
                "59651-300-30",
                "59651-300-90",
                "51862-682-01",
                "51862-682-00",
                "51862-642-60",
                "51862-642-10",
                "51862-643-30",
                "51862-643-10",
                "75907-058-60",
                "75907-058-10",
                "75907-059-30",
                "75907-059-10",
                "0591-2472-18",
                "0591-2472-60",
                "0591-2473-19",
                "0591-2473-30",
                "0378-0144-91",
                "0378-0274-93"
              ],
              "unii": [
                "7FRV7310N6"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "ZOMETA",
            "drugauthorizationnumb": "021223",
            "drugstructuredosagenumb": "4",
            "drugstructuredosageunit": "003",
            "drugdosagetext": "4 MG, QW4",
            "drugadministrationroute": "041",
            "drugindication": "BREAST CANCER METASTATIC",
            "drugstartdateformat": "102",
            "drugstartdate": "20060508",
            "drugenddateformat": "102",
            "drugenddate": "20080508",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "activesubstance": {
              "activesubstancename": "ZOLEDRONIC ACID"
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "AREDIA",
            "drugindication": "METASTASES TO BONE",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "activesubstance": {
              "activesubstancename": "PAMIDRONATE DISODIUM"
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ARIMIDEX",
            "drugstructuredosagenumb": "1",
            "drugstructuredosageunit": "003",
            "drugdosagetext": "1 MG, DAILY",
            "drugadministrationroute": "048",
            "drugindication": "BREAST CANCER STAGE II",
            "drugstartdateformat": "102",
            "drugstartdate": "20010327",
            "drugenddateformat": "102",
            "drugenddate": "20010629",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "activesubstance": {
              "activesubstancename": "ANASTROZOLE"
            },
            "openfda": {
              "application_number": [
                "NDA020541"
              ],
              "brand_name": [
                "ARIMIDEX"
              ],
              "generic_name": [
                "ANASTROZOLE"
              ],
              "manufacturer_name": [
                "ANI Pharmaceuticals, Inc."
              ],
              "product_ndc": [
                "62559-670"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "ANASTROZOLE"
              ],
              "rxcui": [
                "151124",
                "199224"
              ],
              "spl_id": [
                "e8849657-0444-4ca8-bf66-2017f60d5652"
              ],
              "spl_set_id": [
                "acbfaaa9-503c-4691-9828-76a7146ed6de"
              ],
              "package_ndc": [
                "62559-670-30"
              ],
              "nui": [
                "N0000175563",
                "N0000175080"
              ],
              "pharm_class_epc": [
                "Aromatase Inhibitor [EPC]"
              ],
              "pharm_class_moa": [
                "Aromatase Inhibitors [MoA]"
              ],
              "unii": [
                "2Z07MYW1AZ"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ADRIACIN",
            "drugadministrationroute": "042",
            "drugindication": "BREAST CANCER STAGE II",
            "drugstartdateformat": "102",
            "drugstartdate": "20010713",
            "drugenddateformat": "102",
            "drugenddate": "20030525",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "activesubstance": {
              "activesubstancename": "DOXORUBICIN HYDROCHLORIDE"
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "AROMASIN",
            "drugstructuredosagenumb": "1",
            "drugstructuredosageunit": "032",
            "drugdosagetext": "1 DF, UNK",
            "drugadministrationroute": "048",
            "drugindication": "BREAST CANCER STAGE II",
            "drugstartdateformat": "102",
            "drugstartdate": "20030603",
            "drugenddateformat": "102",
            "drugenddate": "20030818",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "activesubstance": {
              "activesubstancename": "EXEMESTANE"
            },
            "openfda": {
              "application_number": [
                "NDA020753"
              ],
              "brand_name": [
                "AROMASIN"
              ],
              "generic_name": [
                "EXEMESTANE"
              ],
              "manufacturer_name": [
                "Pharmacia & Upjohn Company LLC"
              ],
              "product_ndc": [
                "0009-7663"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "EXEMESTANE"
              ],
              "rxcui": [
                "261317",
                "310261"
              ],
              "spl_id": [
                "aacc35a2-0e82-4ba7-bec1-297802d4fa44"
              ],
              "spl_set_id": [
                "cf066b7a-032a-416c-8d40-15ba581423e3"
              ],
              "package_ndc": [
                "0009-7663-04"
              ],
              "nui": [
                "N0000175563",
                "N0000175080"
              ],
              "pharm_class_epc": [
                "Aromatase Inhibitor [EPC]"
              ],
              "pharm_class_moa": [
                "Aromatase Inhibitors [MoA]"
              ],
              "unii": [
                "NY22HMQ4BX"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ENDOXAN",
            "drugadministrationroute": "042",
            "drugindication": "BREAST CANCER STAGE II",
            "drugstartdateformat": "102",
            "drugstartdate": "20010713",
            "drugenddateformat": "102",
            "drugenddate": "20030429",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "activesubstance": {
              "activesubstancename": "CYCLOPHOSPHAMIDE"
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "HYSRON",
            "drugstructuredosagenumb": "3",
            "drugstructuredosageunit": "032",
            "drugdosagetext": "3 DF, UNK",
            "drugadministrationroute": "048",
            "drugindication": "BREAST CANCER STAGE II",
            "drugstartdateformat": "102",
            "drugstartdate": "20040202",
            "drugenddateformat": "102",
            "drugenddate": "20041111",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "activesubstance": {
              "activesubstancename": "MEDROXYPROGESTERONE"
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "ZOMETA",
            "drugauthorizationnumb": "021223",
            "drugindication": "METASTASES TO BONE",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "activesubstance": {
              "activesubstancename": "ZOLEDRONIC ACID"
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "AREDIA",
            "drugstructuredosagenumb": "90",
            "drugstructuredosageunit": "003",
            "drugdosagetext": "90 MG, PER ADMINISTRATION",
            "drugadministrationroute": "041",
            "drugindication": "BREAST CANCER METASTATIC",
            "drugstartdateformat": "102",
            "drugstartdate": "20040819",
            "drugenddateformat": "102",
            "drugenddate": "20060313",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "activesubstance": {
              "activesubstancename": "PAMIDRONATE DISODIUM"
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "TEIROC",
            "drugstructuredosagenumb": "20",
            "drugstructuredosageunit": "003",
            "drugdosagetext": "20 MG, DAILY",
            "drugadministrationroute": "042",
            "drugindication": "METASTASES TO BONE",
            "drugstartdateformat": "102",
            "drugstartdate": "20030722",
            "drugenddateformat": "102",
            "drugenddate": "20040715",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "activesubstance": {
              "activesubstancename": "ALENDRONATE SODIUM"
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "TEIROC",
            "drugindication": "BREAST CANCER STAGE II",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "activesubstance": {
              "activesubstancename": "ALENDRONATE SODIUM"
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ASTHONE",
            "drugstructuredosagenumb": "120",
            "drugstructuredosageunit": "003",
            "drugdosagetext": "120 MG DAILY",
            "drugadministrationroute": "048",
            "drugindication": "BREAST CANCER STAGE II",
            "drugstartdateformat": "102",
            "drugstartdate": "20000627",
            "drugenddateformat": "610",
            "drugenddate": "200106",
            "actiondrug": "1",
            "drugrecurreadministration": "3"
          }
        ],
        "summary": {
          "narrativeincludeclinical": "CASE EVENT DATE: 200710"
        }
      }
    }
  ]
}